These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2840100)

  • 21. Distribution of excitatory and inhibitory amino acid, sigma, monoamine, catecholamine, acetylcholine, opioid, neurotensin, substance P, adenosine and neuropeptide Y receptors in human motor and somatosensory cortex.
    Jansen KL; Faull RL; Dragunow M; Leslie RA
    Brain Res; 1991 Dec; 566(1-2):225-38. PubMed ID: 1726061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of pharmacological receptors in mammalian central nervous system.
    Banerjee PK; Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1989 Apr; 27(4):310-6. PubMed ID: 2553590
    [No Abstract]   [Full Text] [Related]  

  • 23. Radiopharmaceuticals for CNS receptor imaging with SPECT.
    Kung HF
    Int J Rad Appl Instrum B; 1990; 17(1):85-92. PubMed ID: 2155190
    [No Abstract]   [Full Text] [Related]  

  • 24. Possible relationship between antimanic effect and activity of zotepine to 5HT1 receptor.
    Harada T; Ebara T; Otsuki S
    Folia Psychiatr Neurol Jpn; 1984; 38(4):473-80. PubMed ID: 6152586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs.
    Borbe HO; Zierenberg O
    Pharmacopsychiatry; 1985 Sep; 18(5):314-9. PubMed ID: 2996040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
    Chalmers DT; Dewar D; Graham DI; Brooks DN; McCulloch J
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1352-6. PubMed ID: 2154742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotransmitter-receptor binding in various brain regions in ethanol-dependent rats.
    Hunt WA; Dalton TK
    Pharmacol Biochem Behav; 1981 May; 14(5):733-9. PubMed ID: 6113608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug and neurotransmitter receptors in the brain.
    Snyder SH
    Science; 1984 Apr; 224(4644):22-31. PubMed ID: 6322304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor density pattern confirms and enhances the anatomic-functional features of the macaque superior parietal lobule areas.
    Impieri D; Zilles K; Niu M; Rapan L; Schubert N; Galletti C; Palomero-Gallagher N
    Brain Struct Funct; 2019 Nov; 224(8):2733-2756. PubMed ID: 31392403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain.
    Shi D; Nikodijević O; Jacobson KA; Daly JW
    Cell Mol Neurobiol; 1993 Jun; 13(3):247-61. PubMed ID: 8242688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotransmitter receptors in olivopontocerebellar atrophy: an autoradiographic study.
    Whitehouse PJ; Muramoto O; Troncoso JC; Kanazawa I
    Neurology; 1986 Feb; 36(2):193-7. PubMed ID: 2868427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple CNS receptor interactions of ergot alkaloids: affinity and intrinsic activity analysis in in vitro binding systems.
    U'Prichard DC
    Adv Biochem Psychopharmacol; 1980; 23():103-15. PubMed ID: 6249089
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
    Quirion R; Martel JC; Robitaille Y; Etienne P; Wood P; Nair NP; Gauthier S
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):503-10. PubMed ID: 2878714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus.
    Sparks DL; DeKosky ST; Markesbery WR
    Arch Neurol; 1988 Sep; 45(9):994-9. PubMed ID: 2901257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of axon-Schwann cell signaling in the squid nerve fiber.
    Evans PD; Reale V; Merzon RM; Villegas J
    Ann N Y Acad Sci; 1991; 633():434-47. PubMed ID: 1665034
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.
    Crow TJ; Cross AJ; Cooper SJ; Deakin JF; Ferrier IN; Johnson JA; Joseph MH; Owen F; Poulter M; Lofthouse R
    Neuropharmacology; 1984 Dec; 23(12B):1561-9. PubMed ID: 6084823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex.
    Carlson MD; Penney JB; Young AB
    Neurobiol Aging; 1993; 14(4):343-52. PubMed ID: 7690114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
    Gahete MD; Rubio A; Durán-Prado M; Avila J; Luque RM; Castaño JP
    J Alzheimers Dis; 2010; 20(2):465-75. PubMed ID: 20164562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of cholinergic receptors in the rat and human neocortex.
    Zilles K; Schröder H; Schröder U; Horvath E; Werner L; Luiten PG; Maelicke A; Strosberg AD
    EXS; 1989; 57():212-28. PubMed ID: 2558907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.